-
Something wrong with this record ?
Antihyperglycaemic and antiperoxidative effect of Helicteres igora L. bark extracts in streptozotocin-induced diabetic rats
Ganesan Kumar, Gani Sharmila Banu, Arunachalam Ganesan Murugesan, Moses Rajasekara Pandian
Language English Country Czech Republic
NLK
Free Medical Journals
from 2003 to 2013
Freely Accessible Science Journals
from 2003 to 2013
ROAD: Directory of Open Access Scholarly Resources
from 2002
- MeSH
- Antioxidants therapeutic use MeSH
- Diabetes Mellitus, Experimental complications metabolism MeSH
- Hypoglycemic Agents therapeutic use MeSH
- Catalase pharmacokinetics metabolism MeSH
- Plant Bark MeSH
- Lipid Peroxidation genetics radiation effects MeSH
- Rats, Wistar metabolism MeSH
- Reactive Oxygen Species metabolism adverse effects MeSH
- Plant Extracts pharmacokinetics metabolism therapeutic use MeSH
- Malvaceae chemistry metabolism drug effects MeSH
- Streptozocin metabolism adverse effects MeSH
- Superoxide Dismutase pharmacokinetics metabolism MeSH
- Tolbutamide pharmacokinetics metabolism MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
The present investigation shows the antihyperglycaemic activity of aqueous extract of bark of Helicteres isora L. (100, 200mg/kg b.w/p.o) in streptozotocin (STZ) induced diabetic rats. Blood glucose levels, body weight, food and liquid intake were measured on every 5th day over a period of 14 days. A single injection of STZ at a dose of 60mg/kg b.w/i.p elevated the glucose levels >240mg/dl after 5 days. Administration of H.isora at a dose of 100, 200mg/kg/p.o resulted in a significant (p<0.05) reduction in blood glucose levels. Body weights were significantly (p<0.05) reduced in STZ-induced diabetic rats when compared to normal rats while the extract significantly (p<0.05) prevented a decrease in body weight in the H.isora treated animals. The study also evaluated the antioxidant potential of H.isora in STZ-induced diabetic rats. Decreased levels of thiobarbituric acid reactive substances (TBARS), increased levels of reduced glutathione (GSH) and the activities of superoxide dismutase (SOD) and catalase (CAT) resulted in the reduction of free radical formation in various tissues such as liver, kidney, and brain of the diabetic rats. Tolbutamide was used as a standard reference drug. The results clearly indicate that the aqueous extract of bark of Helicteres isora exhibits significant antihyperglycaemic and in vivo antioxidant activity in STZ-induced diabetic rats and the results were found to be dose dependent.
References provided by Crossref.org
Lit.: 33
- 000
- 04099naa 2200541 a 4500
- 001
- bmc07502310
- 003
- CZ-PrNML
- 005
- 20111210121411.0
- 008
- 080306s2007 xr e eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2007.014 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kumar, Ganesan
- 245 10
- $a Antihyperglycaemic and antiperoxidative effect of Helicteres igora L. bark extracts in streptozotocin-induced diabetic rats / $c Ganesan Kumar, Gani Sharmila Banu, Arunachalam Ganesan Murugesan, Moses Rajasekara Pandian
- 314 __
- $a Manonmaniam Sundaranar University, Sri Paramakalyani Centre for Environmental Sciences, Alwarkurichi, Tamilnadu, India
- 504 __
- $a Lit.: 33
- 520 9_
- $a The present investigation shows the antihyperglycaemic activity of aqueous extract of bark of Helicteres isora L. (100, 200mg/kg b.w/p.o) in streptozotocin (STZ) induced diabetic rats. Blood glucose levels, body weight, food and liquid intake were measured on every 5th day over a period of 14 days. A single injection of STZ at a dose of 60mg/kg b.w/i.p elevated the glucose levels >240mg/dl after 5 days. Administration of H.isora at a dose of 100, 200mg/kg/p.o resulted in a significant (p<0.05) reduction in blood glucose levels. Body weights were significantly (p<0.05) reduced in STZ-induced diabetic rats when compared to normal rats while the extract significantly (p<0.05) prevented a decrease in body weight in the H.isora treated animals. The study also evaluated the antioxidant potential of H.isora in STZ-induced diabetic rats. Decreased levels of thiobarbituric acid reactive substances (TBARS), increased levels of reduced glutathione (GSH) and the activities of superoxide dismutase (SOD) and catalase (CAT) resulted in the reduction of free radical formation in various tissues such as liver, kidney, and brain of the diabetic rats. Tolbutamide was used as a standard reference drug. The results clearly indicate that the aqueous extract of bark of Helicteres isora exhibits significant antihyperglycaemic and in vivo antioxidant activity in STZ-induced diabetic rats and the results were found to be dose dependent.
- 650 _2
- $a slézovité $x chemie $x metabolismus $x účinky léků $7 D019660
- 650 _2
- $a streptozocin $x metabolismus $x škodlivé účinky $7 D013311
- 650 _2
- $a kůra rostlin $7 D024301
- 650 _2
- $a rostlinné extrakty $x farmakokinetika $x metabolismus $x terapeutické užití $7 D010936
- 650 _2
- $a hypoglykemika $x terapeutické užití $7 D007004
- 650 _2
- $a antioxidancia $x terapeutické užití $7 D000975
- 650 _2
- $a potkani Wistar $x metabolismus $7 D017208
- 650 _2
- $a experimentální diabetes mellitus $x komplikace $x metabolismus $7 D003921
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $x škodlivé účinky $7 D017382
- 650 _2
- $a peroxidace lipidů $x genetika $x účinky záření $7 D015227
- 650 _2
- $a superoxiddismutasa $x farmakokinetika $x metabolismus $7 D013482
- 650 _2
- $a katalasa $x farmakokinetika $x metabolismus $7 D002374
- 650 _2
- $a tolbutamid $x farmakokinetika $x metabolismus $7 D014044
- 700 1_
- $a Banu, Gani Sharmila
- 700 1_
- $a Murugesan, Arunachalam Ganesan
- 700 1_
- $a Pandian, Moses Rajasekara
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $g Roč. 5, č. 2 (2007), s. 97-104 $x 1214-021X
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2007/02/07.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 1
- 990 __
- $a 20080306093114 $b ABA008
- 991 __
- $a 20080929142841 $b ABA008
- 999 __
- $a ok $b bmc $g 617930 $s 470362
- BAS __
- $a 3
- BMC __
- $a 2007 $b 5 $c 2 $d 97-104 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $a 2007-22/mkal